5-112780935-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000038.6(APC):c.645+32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0837 in 1,372,594 control chromosomes in the GnomAD database, including 5,376 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.067 ( 417 hom., cov: 32)
Exomes 𝑓: 0.086 ( 4959 hom. )
Consequence
APC
NM_000038.6 intron
NM_000038.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.975
Publications
14 publications found
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
- classic or attenuated familial adenomatous polyposisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- desmoid tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- familial adenomatous polyposis 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- gastric adenocarcinoma and proximal polyposis of the stomachInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- APC-related attenuated familial adenomatous polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Turcot syndrome with polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 5-112780935-C-T is Benign according to our data. Variant chr5-112780935-C-T is described in ClinVar as Benign. ClinVar VariationId is 218001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0915 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0674 AC: 10248AN: 151976Hom.: 419 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10248
AN:
151976
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0757 AC: 16861AN: 222672 AF XY: 0.0811 show subpopulations
GnomAD2 exomes
AF:
AC:
16861
AN:
222672
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0857 AC: 104575AN: 1220500Hom.: 4959 Cov.: 17 AF XY: 0.0872 AC XY: 53800AN XY: 616838 show subpopulations
GnomAD4 exome
AF:
AC:
104575
AN:
1220500
Hom.:
Cov.:
17
AF XY:
AC XY:
53800
AN XY:
616838
show subpopulations
African (AFR)
AF:
AC:
853
AN:
27814
American (AMR)
AF:
AC:
1758
AN:
42798
Ashkenazi Jewish (ASJ)
AF:
AC:
1831
AN:
24550
East Asian (EAS)
AF:
AC:
13
AN:
36982
South Asian (SAS)
AF:
AC:
8190
AN:
78922
European-Finnish (FIN)
AF:
AC:
4167
AN:
52560
Middle Eastern (MID)
AF:
AC:
535
AN:
5330
European-Non Finnish (NFE)
AF:
AC:
82988
AN:
899166
Other (OTH)
AF:
AC:
4240
AN:
52378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
4569
9138
13708
18277
22846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2732
5464
8196
10928
13660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0674 AC: 10257AN: 152094Hom.: 417 Cov.: 32 AF XY: 0.0669 AC XY: 4974AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
10257
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
4974
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
1332
AN:
41484
American (AMR)
AF:
AC:
869
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
238
AN:
3470
East Asian (EAS)
AF:
AC:
5
AN:
5184
South Asian (SAS)
AF:
AC:
437
AN:
4824
European-Finnish (FIN)
AF:
AC:
734
AN:
10564
Middle Eastern (MID)
AF:
AC:
41
AN:
292
European-Non Finnish (NFE)
AF:
AC:
6350
AN:
67970
Other (OTH)
AF:
AC:
142
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
481
961
1442
1922
2403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
110
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 15, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial adenomatous polyposis 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.